Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study

W. J. A. Witlox*, B. L. T. Ramaekers, M. A. Joore, A. -M. C. Dingemans, J. Praag, J. Belderbos, C. Tissing-Tan, G. Herder, T. Haitjema, J. F. Ubbels, J. Lagerwaard, S. Y. El Sharouni, J. A. Stigt, E. F. Smitm, H. van Tinteren, V. van der Noort, H. J. M. Groen, D. K. M. De Ruysscher

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)65-71
Number of pages7
JournalRadiotherapy and Oncology
Volume144
DOIs
Publication statusPublished - Mar 2020

Keywords

  • Prophylactic cranial irradiation
  • Non-small cell lung cancer
  • Health-related quality of life
  • WHOLE-BRAIN RADIOTHERAPY
  • HIGH-RISK
  • RTOG 0212
  • TRIAL
  • ONCOLOGY
  • CHEMORADIOTHERAPY
  • QUESTIONNAIRE
  • METASTASES
  • MEMANTINE
  • EUROQOL

Cite this

Witlox, W. J. A., Ramaekers, B. L. T., Joore, M. A., Dingemans, A. -M. C., Praag, J., Belderbos, J., Tissing-Tan, C., Herder, G., Haitjema, T., Ubbels, J. F., Lagerwaard, J., El Sharouni, S. Y., Stigt, J. A., Smitm, E. F., van Tinteren, H., van der Noort, V., Groen, H. J. M., & De Ruysscher, D. K. M. (2020). Health-related quality of life after prophylactic cranial irradiation for stage III non-small cell lung cancer patients: Results from the NVALT-11/DLCRG-02 phase III study. Radiotherapy and Oncology, 144, 65-71. https://doi.org/10.1016/j.radonc.2019.10.016